- Home
- MGX vs TMQ Comparison
MGX vs TMQ Comparison
Compare MGX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGX
- TMQ
- Stock Information
- Founded
- MGX 2018
- TMQ 2004
- Country
- MGX United States
- TMQ Canada
- Employees
- MGX N/A
- TMQ N/A
- Industry
- MGX
- TMQ Precious Metals
- Sector
- MGX
- TMQ Basic Materials
- Exchange
- MGX NYSE
- TMQ Nasdaq
- Market Cap
- MGX 70.4M
- TMQ 83.6M
- IPO Year
- MGX 2024
- TMQ N/A
- Fundamental
- Price
- MGX $3.55
- TMQ $1.10
- Analyst Decision
- MGX Strong Buy
- TMQ
- Analyst Count
- MGX 7
- TMQ 0
- Target Price
- MGX $16.67
- TMQ N/A
- AVG Volume (30 Days)
- MGX 4.5M
- TMQ 439.1K
- Earning Date
- MGX 02-12-2025
- TMQ 02-07-2025
- Dividend Yield
- MGX N/A
- TMQ N/A
- EPS Growth
- MGX N/A
- TMQ N/A
- EPS
- MGX N/A
- TMQ N/A
- Revenue
- MGX $55,080,000.00
- TMQ N/A
- Revenue This Year
- MGX $11.59
- TMQ N/A
- Revenue Next Year
- MGX N/A
- TMQ N/A
- P/E Ratio
- MGX N/A
- TMQ N/A
- Revenue Growth
- MGX 45.13
- TMQ N/A
- 52 Week Low
- MGX $1.61
- TMQ $0.25
- 52 Week High
- MGX $12.74
- TMQ $1.40
- Technical
- Relative Strength Index (RSI)
- MGX 64.37
- TMQ 51.44
- Support Level
- MGX $2.91
- TMQ $1.08
- Resistance Level
- MGX $3.63
- TMQ $1.20
- Average True Range (ATR)
- MGX 0.54
- TMQ 0.08
- MACD
- MGX 0.09
- TMQ -0.02
- Stochastic Oscillator
- MGX 55.66
- TMQ 38.46
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.